View Post

Drug to Replace Chemotherapy May Reshape Cancer Care

In In The News by Barbara Jacoby

By: Kanoko Matsuyama From: bloomberg.com * Promising treatment may reach far more breast cancer patients * Daiichi drug may outsell Roche’s Herceptin, spark dealmaking A class of drugs is emerging that can attack cancer cells in the body without damaging surrounding healthy ones. They have the potential to replace chemotherapy and its disruptive side effects, reshaping the future of cancer …

View Post

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

In In The News by Barbara Jacoby

From: PR Newswire — Breakthrough Therapy designation received for the treatment of patients with HER2-positive, locally advanced or metastatic breast cancer who have been treated with trastuzumab and pertuzumab and have disease progression after ado-trastuzumab emtansine (T-DM1) — HER2-positive metastatic breast cancer often advances to the point where no currently approved HER2-targeted treatments continue to control the disease — Designation …